InflaRx

IFRX

#9635

Rank

NZ$0.12 B

Marketcap

🇩🇪 Germany

Country

NZ$1.71

Share price

-2.91%

Change (1 day)

8.67%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

Annual Reports (20-F)

Latest form 20-F annual reports for InflaRx CIK: 0001708688
The 20-F is a 10-K equivalent for non-US companies, as a foreight company InflaRx only files 20-F reports

20-F Annual Report 2026-03-20

Language: English

View Annual Report (20-F)

20-F Annual Report 2025-03-20

Language: English

View Annual Report (20-F)

20-F Annual Report 2024-03-21

Language: English

View Annual Report (20-F)

20-F Annual Report 2023-03-22

Language: English

View Annual Report (20-F)

20-F Annual Report 2022-03-24

Language: English

View Annual Report (20-F)

20-F Annual Report 2021-03-25

Language: English

View Annual Report (20-F)

20-F Annual Report 2020-04-29

Language: English

View Annual Report (20-F)

20-F Annual Report 2019-03-28

Language: English

View Annual Report (20-F)

20-F Annual Report 2018-03-29

Language: English

View Annual Report (20-F)

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions